Effect of Indobufen and Aspirin on Platelet Aggregation and Long Term Prognosis in Patients With Coronary Heart Disease

Hirudin Plus Aspirin in the Secondary Prevention of Cardioembolic Stroke Due to Nonvalvular Atrial Fibrillation

NCT02181361 ·Status: COMPLETED

Platelet Drug Trial in Coronary Disease Progression

NCT00000496 ·Status: COMPLETED ·Phase: PHASE3

Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)

NCT04624854 ·Status: COMPLETED ·Phase: PHASE4

Platelet-Inhibitor Drug Trial in Coronary Angioplasty

NCT00000510 ·Status: COMPLETED ·Phase: PHASE3

The Middle East Dual Anti-platelet Treatment in Acute Transient Ischemic Attack

NCT02144831 ·Status: WITHDRAWN ·Phase: PHASE4

Synergy Between Stent and Drugs to Avoid Ischemic Recurrences After Percutaneous Coronary Intervention

NCT00611286 ·Status: COMPLETED ·Phase: PHASE4

Optimizing Aspirin and Clopidogrel Therapy (BOchum CLopidogrel and Aspirin Plan)

NCT01212302 ·Status: COMPLETED ·Phase: NA

Loss of Effect of Aspirin on Platelet Aggregation During Chronic Administration

NCT00748371 ·Status: TERMINATED ·Phase: PHASE4

Impact of Evolocumab on the Antiplatelet Effects of Ticagrelor and Aspirin in Patients With Acute Coronary Syndrome

NCT05418166 ·Status: UNKNOWN

IndObufen Versus asPirin After Coronary Drug-eluting Stent implantaTION in Elderly Patients With Acute Coronary Syndrome

NCT06451198 ·Status: RECRUITING ·Phase: PHASE4

Pharmacodynamic Effects of Dabigatran in Patients on Dual Antiplatelet Therapy

NCT01852162 ·Status: COMPLETED ·Phase: NA

NSAIDs in Coronary Artery Disease Patients

NCT01402804 ·Status: COMPLETED

Long-term Follow-up of antithrombotIc Management Patterns in Acute Coronary Syndrome Patients in Asia-China Extension

NCT02305680 ·Status: COMPLETED

Effect of Antithrombotic Treatment in Patients With Both Coronary Heart Disease and Atrial Fibrillation

NCT03051061 ·Status: UNKNOWN

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AZD3366 in Healthy Subjects, Japanese and Chinese Subjects

NCT04588727 ·Status: COMPLETED ·Phase: PHASE1

Dose-related Effect of Aspirin on Laboratory-defined Acetylsalicylic Acid Resistance and Clinical Outcome After Coronary Stenting

NCT00966485 ·Status: COMPLETED ·Phase: NA

Optimal Duration of Dual Antiplatelet Therapy After Drug-eluting Stent Implantation

NCT00822536 ·Status: COMPLETED ·Phase: PHASE4

Aspirin Dose and Atherosclerosis in Patients With Heart Disease

NCT00272337 ·Status: COMPLETED ·Phase: PHASE4

Mechanisms of Action of Acetaminophen

NCT00646906 ·Status: COMPLETED ·Phase: NA

Long-tErm Follow-uP of antithrombotIc Management Patterns In Acute CORonary Syndrome Patients in Asia

NCT01361386 ·Status: COMPLETED

Residual Platelet Activity Despite Aspirin Utilization in Coronary Heart Disease

NCT01820429 ·Status: COMPLETED

Use Of SB424323 With Aspirin In Non-Valvular Atrial Fibrillation In Patients At A Low Or Intermediate Risk For Stroke

NCT00240643 ·Status: COMPLETED ·Phase: PHASE2

Atorvastatin, Aspirin, Oxidative Stress, Coagulation and Platelet Activation Indexes

NCT01322711 ·Status: UNKNOWN ·Phase: PHASE4

Coronary Artery Ectasia, Efficacy of Various Anti Thrombotic Regimens.

NCT05718531 ·Status: UNKNOWN ·Phase: PHASE3

Aspirin Twice Daily in Diabetic Patients With Coronary Artery Disease

NCT01617031 ·Status: COMPLETED